Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - Chief Executive Officer Cedric O'Gorman - Chief Medical Officer Maged Shenouda - Maged Shenouda Conference Call Participants Rudy Li - SVB Securities Uy Ear - Mizuho Andrew Tsai - Jefferies Andrea Tan - Goldman Sachs Yatin Suneja - Guggenheim Partners Operator Good afternoon. Thank you for attending today's Relmada Therapeutics Inc. First Qu ...